Literature DB >> 11815603

Involvement of sphingosine kinase in TNF-alpha-stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells.

Lewis R Vann1, Shawn G Payne, Lisa C Edsall, Sharon Twitty, Sarah Spiegel, Sheldon Milstien.   

Abstract

In C6 glioma cells, the sphingolipid second messenger ceramide potentiates expression of inducible nitric-oxide synthase (iNOS) induced by tumor necrosis factor alpha (TNF-alpha) without affecting GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme in the biosynthesis of 6(R)-5,6,7,8-tetrahydrobiopterin (BH(4)), a cofactor required for iNOS activity. TNF-alpha also stimulates sphingosine kinase, the enzyme that phosphorylates sphingosine to form sphingosine-1-phosphate (SPP), a further metabolite of ceramide. Several clones of C6 cells, expressing widely varying levels of sphingosine kinase, were used to examine the role of SPP in regulation of GTPCH and BH(4) biosynthesis. Overexpression of sphingosine kinase, with concomitant increased endogenous SPP levels, potentiated the effect of TNF-alpha on GTPCH expression and activity and BH(4) biosynthesis. In contrast, enforced expression of sphingosine kinase had no effect on iNOS expression or NO formation. Furthermore, N,N-dimethylsphingosine, a potent sphingosine kinase inhibitor, completely eliminated the increased GTPCH activity and expression induced by TNF-alpha. Surprisingly, we found that, although C6 cells can secrete SPP, which is enhanced by TNF-alpha, treatment of C6 cells with exogenous SPP or dihydro-SPP had no affect on BH(4) biosynthesis. However, both SPP and dihydro-SPP markedly stimulated ERK 1/2 in C6 cells, which express cell surface SPP receptors. Interestingly, although this ERK activation was blocked by PD98059, which also reduced cellular proliferation induced by enforced expression of sphingosine kinase, PD98059 had no effect on GTPCH activity. Collectively, these results suggest that only intracellularly generated SPP plays a role in regulation of GTPCH and BH(4) levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815603     DOI: 10.1074/jbc.M109111200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.

Authors:  H Zhang; W Li; S Sun; S Yu; M Zhang; F Zou
Journal:  Cell Prolif       Date:  2012-01-30       Impact factor: 6.831

Review 2.  Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

3.  Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.

Authors:  Alexander A Chumanevich; Deepak Poudyal; Xiangli Cui; Tia Davis; Patricia A Wood; Charles D Smith; Lorne J Hofseth
Journal:  Carcinogenesis       Date:  2010-08-05       Impact factor: 4.944

Review 4.  Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.

Authors:  Ashley J Snider; K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

Review 5.  The outs and the ins of sphingosine-1-phosphate in immunity.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Immunol       Date:  2011-05-06       Impact factor: 53.106

Review 6.  Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.

Authors:  Augusta Pisanu; Laura Boi; Giovanna Mulas; Saturnino Spiga; Sandro Fenu; Anna R Carta
Journal:  J Neural Transm (Vienna)       Date:  2018-03-14       Impact factor: 3.575

7.  Expression of sphingosine kinase gene in the interactions between human gastric carcinoma cell and vascular endothelial cell.

Authors:  Juan Ren; Lei Dong; Cang-Bao Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

8.  Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation.

Authors:  Gregory Kapatos; Prashanthi Vunnava; Yanning Wu
Journal:  J Neurochem       Date:  2007-03-29       Impact factor: 5.372

9.  Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.

Authors:  Kevin J French; Yan Zhuang; Lynn W Maines; Peng Gao; Wenxue Wang; Vladimir Beljanski; John J Upson; Cecelia L Green; Staci N Keller; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2010-01-08       Impact factor: 4.030

10.  Distribution of sphingosine kinase activity and mRNA in rodent brain.

Authors:  Nicolas Blondeau; Yushuan Lai; Sarah Tyndall; Margherita Popolo; Kamil Topalkara; James K Pru; Ling Zhang; Hyunghwan Kim; James K Liao; Kan Ding; Christian Waeber
Journal:  J Neurochem       Date:  2007-07-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.